FENC logo

Fennec Pharmaceuticals (FENC) Selling, General & Administrative Expenses

Annual SGA

$32.71 M
+$12.20 M+59.50%

December 31, 2023


Summary


Performance

FENC SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFENCexpensesmetrics:

Quarterly SGA

$10.72 M
-$814.00 K-7.06%

September 30, 2024


Summary


Performance

FENC Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFENCexpensesmetrics:

TTM SGA

-$855.31 M
-$1.13 M-0.13%

September 30, 2024


Summary


Performance

FENC TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFENCexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

FENC Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+59.5%-7.1%-2204.5%
3 y3 years+152.6%+56.6%-3487.9%
5 y5 years+505.6%+56.6%-3487.9%

FENC Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+167.2%-7.1%+408.4%-23.6%+0.5%
5 y5-yearat high+341.9%-7.1%+408.4%-53.6%+0.5%
alltimeall timeat high+5225.3%-7.1%>+9999.0%<-9999.0%+0.5%

Fennec Pharmaceuticals Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$10.72 M(-7.1%)
$44.17 M(+8.7%)
Jun 2024
-
$11.54 M(+4.1%)
$40.64 M(+10.0%)
Mar 2024
-
$11.08 M(+2.3%)
$36.94 M(+12.9%)
Dec 2023
$32.71 M(+59.5%)
$10.84 M(+50.7%)
$32.71 M(+11.5%)
Sep 2023
-
$7.19 M(-8.2%)
$29.34 M(+0.5%)
Jun 2023
-
$7.83 M(+14.4%)
$29.20 M(+15.7%)
Mar 2023
-
$6.85 M(-8.3%)
$25.25 M(+23.1%)
Dec 2022
$20.51 M(+67.5%)
$7.47 M(+5.9%)
$20.51 M(+22.6%)
Sep 2022
-
$7.05 M(+81.9%)
$16.72 M(+32.7%)
Jun 2022
-
$3.88 M(+83.9%)
$12.60 M(+6.4%)
Mar 2022
-
$2.11 M(-42.8%)
$11.84 M(-3.3%)
Dec 2021
$12.24 M(-5.5%)
$3.68 M(+25.7%)
$12.24 M(+12.8%)
Sep 2021
-
$2.93 M(-6.1%)
$10.85 M(-12.6%)
Jun 2021
-
$3.12 M(+24.5%)
$12.41 M(-4.6%)
Mar 2021
-
$2.51 M(+9.3%)
$13.02 M(+0.5%)
Dec 2020
$12.95 M(+75.0%)
$2.29 M(-48.9%)
$12.95 M(-1.4%)
Sep 2020
-
$4.49 M(+20.6%)
$13.14 M(+35.2%)
Jun 2020
-
$3.72 M(+52.5%)
$9.71 M(+10.0%)
Mar 2020
-
$2.44 M(-1.6%)
$8.84 M(+19.4%)
Dec 2019
$7.40 M(+37.0%)
$2.48 M(+132.3%)
$7.40 M(+17.4%)
Sep 2019
-
$1.07 M(-62.4%)
$6.30 M(+0.3%)
Jun 2019
-
$2.84 M(+181.9%)
$6.29 M(+18.4%)
Mar 2019
-
$1.01 M(-27.0%)
$5.31 M(-1.7%)
Dec 2018
$5.40 M(+7.7%)
$1.38 M(+31.6%)
$5.40 M(-4.4%)
Sep 2018
-
$1.05 M(-43.8%)
$5.65 M(-10.2%)
Jun 2018
-
$1.87 M(+69.4%)
$6.29 M(+12.9%)
Mar 2018
-
$1.10 M(-32.4%)
$5.57 M(+11.1%)
Dec 2017
$5.01 M(+109.0%)
$1.63 M(-3.8%)
$5.01 M(+15.1%)
Sep 2017
-
$1.69 M(+47.8%)
$4.36 M(+39.9%)
Jun 2017
-
$1.15 M(+109.9%)
$3.12 M(+22.8%)
Mar 2017
-
$546.00 K(-43.8%)
$2.54 M(+5.8%)
Dec 2016
$2.40 M(+46.8%)
$972.00 K(+115.0%)
$2.40 M(+25.8%)
Sep 2016
-
$452.00 K(-20.4%)
$1.91 M(+11.8%)
Jun 2016
-
$568.00 K(+39.6%)
$1.71 M(+4.5%)
Mar 2016
-
$407.00 K(-15.2%)
$1.63 M(-0.1%)
Dec 2015
$1.63 M(-35.2%)
$480.00 K(+92.0%)
$1.63 M(-8.2%)
Sep 2015
-
$250.00 K(-49.5%)
$1.78 M(-13.6%)
Jun 2015
-
$495.00 K(+21.0%)
$2.06 M(-15.0%)
Mar 2015
-
$409.00 K(-34.7%)
$2.42 M(-3.8%)
Dec 2014
$2.52 M(+88.9%)
$626.00 K(+17.9%)
$2.52 M(+13.5%)
Sep 2014
-
$531.00 K(-38.1%)
$2.22 M(+13.0%)
Jun 2014
-
$858.00 K(+69.9%)
$1.96 M(+32.8%)
Mar 2014
-
$505.00 K(+54.9%)
$1.48 M(+11.0%)
Dec 2013
$1.33 M(-13.7%)
$326.00 K(+18.5%)
$1.33 M(-15.0%)
Sep 2013
-
$275.00 K(-26.3%)
$1.57 M(+0.1%)
Jun 2013
-
$373.00 K(+3.9%)
$1.57 M(-1.1%)
Mar 2013
-
$359.00 K(-36.1%)
$1.58 M(+2.5%)
DateAnnualQuarterlyTTM
Dec 2012
$1.54 M(-20.5%)
$562.00 K(+105.9%)
$1.54 M(+12.0%)
Sep 2012
-
$273.00 K(-30.0%)
$1.38 M(-14.4%)
Jun 2012
-
$390.00 K(+21.9%)
$1.61 M(+3.3%)
Mar 2012
-
$320.00 K(-19.2%)
$1.56 M(-19.8%)
Dec 2011
$1.94 M(-50.1%)
$396.00 K(-21.6%)
$1.95 M(-6.3%)
Sep 2011
-
$505.00 K(+49.4%)
$2.08 M(-12.7%)
Jun 2011
-
$338.00 K(-52.1%)
$2.38 M(-45.9%)
Mar 2011
-
$706.00 K(+34.0%)
$4.40 M(+12.9%)
Dec 2010
$3.90 M(+220.9%)
$527.00 K(-34.7%)
$3.90 M(+17.8%)
Sep 2010
-
$807.00 K(-65.8%)
$3.31 M(+18.4%)
Jun 2010
-
$2.36 M(+1062.1%)
$2.79 M(+274.9%)
Mar 2010
-
$203.00 K(-427.4%)
$745.00 K(-38.7%)
Dec 2009
$1.21 M(-65.5%)
-$62.00 K(-121.2%)
$1.22 M(-47.6%)
Sep 2009
-
$293.00 K(-5.8%)
$2.32 M(-7.4%)
Jun 2009
-
$311.00 K(-53.8%)
$2.50 M(-20.1%)
Mar 2009
-
$673.00 K(-35.4%)
$3.13 M(-11.0%)
Dec 2008
$3.52 M(+7.4%)
$1.04 M(+118.0%)
$3.52 M(+15.8%)
Sep 2008
-
$478.00 K(-49.1%)
$3.04 M(-13.8%)
Jun 2008
-
$939.00 K(-11.5%)
$3.53 M(+4.3%)
Mar 2008
-
$1.06 M(+89.1%)
$3.38 M(+3.1%)
Dec 2007
$3.28 M(+13.7%)
$561.00 K(-41.9%)
$3.28 M(-5.5%)
Sep 2007
-
$966.00 K(+21.8%)
$3.47 M(+9.2%)
Jun 2007
-
$793.00 K(-17.2%)
$3.18 M(+2.7%)
Mar 2007
-
$958.00 K(+27.4%)
$3.09 M(+7.3%)
Dec 2006
$2.88 M(-9.4%)
$752.00 K(+11.7%)
$2.88 M(+5.9%)
Sep 2006
-
$673.00 K(-5.3%)
$2.72 M(-9.9%)
Jun 2006
-
$711.00 K(-4.8%)
$3.02 M(-5.9%)
Mar 2006
-
$747.00 K(+26.4%)
$3.21 M(+0.9%)
Dec 2005
$3.18 M(-8.9%)
$591.10 K(-39.2%)
$3.18 M(+22.8%)
Sep 2005
-
$972.90 K(+8.1%)
$2.59 M(-9.8%)
Jun 2005
-
$900.00 K(+25.3%)
$2.87 M(-15.8%)
Mar 2005
-
$718.00 K(-42.7%)
$3.41 M(-20.7%)
Sep 2004
-
$1.25 M(-12.9%)
$4.30 M(+23.1%)
Jun 2004
$3.49 M(+56.1%)
$1.44 M(+55.0%)
$3.49 M(+11.6%)
Mar 2004
-
$928.60 K(+36.7%)
$3.13 M(+8.5%)
Dec 2003
-
$679.20 K(+52.4%)
$2.88 M(+17.4%)
Sep 2003
-
$445.70 K(-58.5%)
$2.46 M(+11.5%)
Jun 2003
$2.24 M(+88.9%)
$1.08 M(+57.0%)
$2.20 M(+32.2%)
Mar 2003
-
$684.70 K(+171.3%)
$1.67 M(+40.7%)
Dec 2002
-
$252.40 K(+31.5%)
$1.19 M(+4.7%)
Sep 2002
-
$191.90 K(-64.3%)
$1.13 M(-4.4%)
Jun 2002
$1.18 M(+60.3%)
$538.20 K(+165.5%)
$1.18 M(+83.4%)
Mar 2002
-
$202.70 K(+1.9%)
$645.20 K(+45.8%)
Dec 2001
-
$198.90 K(-18.3%)
$442.50 K(-4.5%)
Sep 2001
-
$243.60 K(+10.8%)
$463.40 K(+110.8%)
Jun 2001
$738.70 K(+20.3%)
-
-
Dec 2000
-
$219.80 K
$219.80 K
Jun 2000
$614.20 K
-
-

FAQ

  • What is Fennec Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Fennec Pharmaceuticals?
  • What is Fennec Pharmaceuticals annual SGA year-on-year change?
  • What is Fennec Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Fennec Pharmaceuticals?
  • What is Fennec Pharmaceuticals quarterly SGA year-on-year change?
  • What is Fennec Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Fennec Pharmaceuticals?
  • What is Fennec Pharmaceuticals TTM SGA year-on-year change?

What is Fennec Pharmaceuticals annual SGA?

The current annual SGA of FENC is $32.71 M

What is the all time high annual SGA for Fennec Pharmaceuticals?

Fennec Pharmaceuticals all-time high annual SGA is $32.71 M

What is Fennec Pharmaceuticals annual SGA year-on-year change?

Over the past year, FENC annual SGA has changed by +$12.20 M (+59.50%)

What is Fennec Pharmaceuticals quarterly SGA?

The current quarterly SGA of FENC is $10.72 M

What is the all time high quarterly SGA for Fennec Pharmaceuticals?

Fennec Pharmaceuticals all-time high quarterly SGA is $11.54 M

What is Fennec Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, FENC quarterly SGA has changed by -$814.00 K (-7.06%)

What is Fennec Pharmaceuticals TTM SGA?

The current TTM SGA of FENC is -$855.31 M

What is the all time high TTM SGA for Fennec Pharmaceuticals?

Fennec Pharmaceuticals all-time high TTM SGA is -$4.02 M

What is Fennec Pharmaceuticals TTM SGA year-on-year change?

Over the past year, FENC TTM SGA has changed by -$895.95 M (-2204.50%)